BLUELINX HOLDINGS INC (BXC) Fundamental Analysis & Valuation

NYSE:BXC • US09624H2085

Current stock price

45.34 USD
-1.13 (-2.43%)
At close:
45.34 USD
0 (0%)
After Hours:

This BXC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. BXC Profitability Analysis

1.1 Basic Checks

  • BXC had positive earnings in the past year.
  • In the past year BXC had a positive cash flow from operations.
  • In the past 5 years BXC has always been profitable.
  • In the past 5 years BXC always reported a positive cash flow from operatings.
BXC Yearly Net Income VS EBIT VS OCF VS FCFBXC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M

1.2 Ratios

  • BXC has a worse Return On Assets (0.01%) than 60.42% of its industry peers.
  • With a Return On Equity value of 0.04%, BXC is not doing good in the industry: 62.50% of the companies in the same industry are doing better.
  • The Return On Invested Capital of BXC (1.69%) is worse than 66.67% of its industry peers.
  • BXC had an Average Return On Invested Capital over the past 3 years of 4.86%. This is below the industry average of 9.03%.
Industry RankSector Rank
ROA 0.01%
ROE 0.04%
ROIC 1.69%
ROA(3y)2.18%
ROA(5y)9.78%
ROE(3y)5.3%
ROE(5y)29.53%
ROIC(3y)4.86%
ROIC(5y)14.09%
BXC Yearly ROA, ROE, ROICBXC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 200 300

1.3 Margins

  • Looking at the Profit Margin, with a value of 0.01%, BXC is doing worse than 62.50% of the companies in the same industry.
  • BXC's Profit Margin has declined in the last couple of years.
  • BXC has a worse Operating Margin (1.02%) than 68.75% of its industry peers.
  • BXC's Operating Margin has declined in the last couple of years.
  • BXC's Gross Margin of 15.29% is on the low side compared to the rest of the industry. BXC is outperformed by 85.42% of its industry peers.
  • BXC's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 1.02%
PM (TTM) 0.01%
GM 15.29%
OM growth 3Y-51.87%
OM growth 5Y-23.7%
PM growth 3Y-89.63%
PM growth 5Y-69.05%
GM growth 3Y-6.52%
GM growth 5Y-0.17%
BXC Yearly Profit, Operating, Gross MarginsBXC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. BXC Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BXC is destroying value.
  • Compared to 1 year ago, BXC has less shares outstanding
  • Compared to 5 years ago, BXC has less shares outstanding
  • Compared to 1 year ago, BXC has a worse debt to assets ratio.
BXC Yearly Shares OutstandingBXC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M
BXC Yearly Total Debt VS Total AssetsBXC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • BXC has an Altman-Z score of 3.27. This indicates that BXC is financially healthy and has little risk of bankruptcy at the moment.
  • With a Altman-Z score value of 3.27, BXC perfoms like the industry average, outperforming 58.33% of the companies in the same industry.
  • BXC has a debt to FCF ratio of 18.81. This is a negative value and a sign of low solvency as BXC would need 18.81 years to pay back of all of its debts.
  • With a Debt to FCF ratio value of 18.81, BXC perfoms like the industry average, outperforming 52.08% of the companies in the same industry.
  • A Debt/Equity ratio of 0.96 indicates that BXC is somewhat dependend on debt financing.
  • The Debt to Equity ratio of BXC (0.96) is worse than 60.42% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.96
Debt/FCF 18.81
Altman-Z 3.27
ROIC/WACC0.19
WACC8.83%
BXC Yearly LT Debt VS Equity VS FCFBXC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 4.66 indicates that BXC has no problem at all paying its short term obligations.
  • BXC's Current ratio of 4.66 is amongst the best of the industry. BXC outperforms 95.83% of its industry peers.
  • BXC has a Quick Ratio of 3.12. This indicates that BXC is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 3.12, BXC belongs to the top of the industry, outperforming 95.83% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.66
Quick Ratio 3.12
BXC Yearly Current Assets VS Current LiabilitesBXC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. BXC Growth Analysis

3.1 Past

  • The earnings per share for BXC have decreased strongly by -85.11% in the last year.
  • The earnings per share for BXC have been decreasing by -35.32% on average. This is quite bad
  • Looking at the last year, BXC shows a small growth in Revenue. The Revenue has grown by 0.05% in the last year.
  • Measured over the past years, BXC shows a decrease in Revenue. The Revenue has been decreasing by -0.94% on average per year.
EPS 1Y (TTM)-85.11%
EPS 3Y-68.55%
EPS 5Y-35.32%
EPS Q2Q%-177.05%
Revenue 1Y (TTM)0.05%
Revenue growth 3Y-12.77%
Revenue growth 5Y-0.94%
Sales Q2Q%0.73%

3.2 Future

  • Based on estimates for the next years, BXC will show a very strong growth in Earnings Per Share. The EPS will grow by 85.45% on average per year.
  • Based on estimates for the next years, BXC will show a small growth in Revenue. The Revenue will grow by 4.77% on average per year.
EPS Next Y-41.26%
EPS Next 2Y85.45%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.44%
Revenue Next 2Y4.77%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BXC Yearly Revenue VS EstimatesBXC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B
BXC Yearly EPS VS EstimatesBXC Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 10 20 30

More info and screens

Find the best growth stocksShow best growing peers

3

4. BXC Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 47.73 indicates a quite expensive valuation of BXC.
  • Compared to the rest of the industry, the Price/Earnings ratio of BXC indicates a slightly more expensive valuation: BXC is more expensive than 64.58% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 25.23, BXC is valued quite expensively.
  • The Price/Forward Earnings ratio is 81.25, which means the current valuation is very expensive for BXC.
  • BXC's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. BXC is more expensive than 68.75% of the companies in the same industry.
  • BXC's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 23.28.
Industry RankSector Rank
PE 47.73
Fwd PE 81.25
BXC Price Earnings VS Forward Price EarningsBXC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • 81.25% of the companies in the same industry are more expensive than BXC, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of BXC indicates a rather cheap valuation: BXC is cheaper than 93.75% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 10.86
EV/EBITDA 8.41
BXC Per share dataBXC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 100 200 300

4.3 Compensation for Growth

  • BXC's earnings are expected to grow with 85.45% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y85.45%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BXC Dividend Analysis

5.1 Amount

  • BXC does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BXC Fundamentals: All Metrics, Ratios and Statistics

BLUELINX HOLDINGS INC

NYSE:BXC (3/20/2026, 8:04:00 PM)

After market: 45.34 0 (0%)

45.34

-1.13 (-2.43%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)02-24
Earnings (Next)04-27
Inst Owners100.59%
Inst Owner Change1.59%
Ins Owners2.21%
Ins Owner Change0.01%
Market Cap356.83M
Revenue(TTM)2.95B
Net Income(TTM)219.00K
Analysts77.5
Price Target78.03 (72.1%)
Short Float %6.34%
Short Ratio5.05
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-16.66%
Min EPS beat(2)-23.18%
Max EPS beat(2)-10.14%
EPS beat(4)1
Avg EPS beat(4)-14.28%
Min EPS beat(4)-24.67%
Max EPS beat(4)0.88%
EPS beat(8)4
Avg EPS beat(8)9.11%
EPS beat(12)7
Avg EPS beat(12)11.85%
EPS beat(16)10
Avg EPS beat(16)12.41%
Revenue beat(2)1
Avg Revenue beat(2)-0.69%
Min Revenue beat(2)-2.07%
Max Revenue beat(2)0.69%
Revenue beat(4)1
Avg Revenue beat(4)-1.06%
Min Revenue beat(4)-2.07%
Max Revenue beat(4)0.69%
Revenue beat(8)3
Avg Revenue beat(8)-0.71%
Revenue beat(12)3
Avg Revenue beat(12)-2.91%
Revenue beat(16)5
Avg Revenue beat(16)-1.52%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-98.67%
EPS NQ rev (3m)-108.39%
EPS NY rev (1m)-70.61%
EPS NY rev (3m)-71.45%
Revenue NQ rev (1m)1.94%
Revenue NQ rev (3m)1.64%
Revenue NY rev (1m)1.34%
Revenue NY rev (3m)1.21%
Valuation
Industry RankSector Rank
PE 47.73
Fwd PE 81.25
P/S 0.12
P/FCF 10.86
P/OCF 5.97
P/B 0.58
P/tB 0.77
EV/EBITDA 8.41
EPS(TTM)0.95
EY2.1%
EPS(NY)0.56
Fwd EY1.23%
FCF(TTM)4.17
FCFY9.21%
OCF(TTM)7.6
OCFY16.75%
SpS375.35
BVpS78.44
TBVpS58.88
PEG (NY)N/A
PEG (5Y)N/A
Graham Number40.95
Profitability
Industry RankSector Rank
ROA 0.01%
ROE 0.04%
ROCE 2.25%
ROIC 1.69%
ROICexc 2.37%
ROICexgc 2.83%
OM 1.02%
PM (TTM) 0.01%
GM 15.29%
FCFM 1.11%
ROA(3y)2.18%
ROA(5y)9.78%
ROE(3y)5.3%
ROE(5y)29.53%
ROIC(3y)4.86%
ROIC(5y)14.09%
ROICexc(3y)7.81%
ROICexc(5y)17.95%
ROICexgc(3y)8.79%
ROICexgc(5y)19.65%
ROCE(3y)6.47%
ROCE(5y)18.75%
ROICexgc growth 3Y-56.47%
ROICexgc growth 5Y-25.31%
ROICexc growth 3Y-57.61%
ROICexc growth 5Y-26.66%
OM growth 3Y-51.87%
OM growth 5Y-23.7%
PM growth 3Y-89.63%
PM growth 5Y-69.05%
GM growth 3Y-6.52%
GM growth 5Y-0.17%
F-Score5
Asset Turnover1.91
Health
Industry RankSector Rank
Debt/Equity 0.96
Debt/FCF 18.81
Debt/EBITDA 8.51
Cap/Depr 67.49%
Cap/Sales 0.91%
Interest Coverage 0.64
Cash Conversion 85.42%
Profit Quality 15000.5%
Current Ratio 4.66
Quick Ratio 3.12
Altman-Z 3.27
F-Score5
WACC8.83%
ROIC/WACC0.19
Cap/Depr(3y)85.86%
Cap/Depr(5y)87.75%
Cap/Sales(3y)1.05%
Cap/Sales(5y)0.86%
Profit Quality(3y)5219.88%
Profit Quality(5y)3165.36%
High Growth Momentum
Growth
EPS 1Y (TTM)-85.11%
EPS 3Y-68.55%
EPS 5Y-35.32%
EPS Q2Q%-177.05%
EPS Next Y-41.26%
EPS Next 2Y85.45%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.05%
Revenue growth 3Y-12.77%
Revenue growth 5Y-0.94%
Sales Q2Q%0.73%
Revenue Next Year4.44%
Revenue Next 2Y4.77%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-65.73%
EBIT growth 3Y-58.02%
EBIT growth 5Y-24.42%
EBIT Next Year80.11%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-27.11%
FCF growth 3Y-55.16%
FCF growth 5Y-8.53%
OCF growth 1Y-29.81%
OCF growth 3Y-46.94%
OCF growth 5Y1.68%

BLUELINX HOLDINGS INC / BXC Fundamental Analysis FAQ

What is the fundamental rating for BXC stock?

ChartMill assigns a fundamental rating of 4 / 10 to BXC.


What is the valuation status of BLUELINX HOLDINGS INC (BXC) stock?

ChartMill assigns a valuation rating of 3 / 10 to BLUELINX HOLDINGS INC (BXC). This can be considered as Overvalued.


What is the profitability of BXC stock?

BLUELINX HOLDINGS INC (BXC) has a profitability rating of 2 / 10.


How financially healthy is BLUELINX HOLDINGS INC?

The financial health rating of BLUELINX HOLDINGS INC (BXC) is 6 / 10.